Great Portland Estates PLC
23 February 2001
GREAT PORTLAND ESTATES SELLS £66 MILLION IN
NEXT PHASE OF RATIONALISATION
In two separate transactions Great Portland Estates has exchanged contracts to
sell seven non-core offices for a total consideration of £66 million. In the
major disposal a joint venture between Greenwich Group International and J E R
Partners has purchased buildings in Aberdeen, Birmingham, Chatham, Glasgow and
Whitechapel Road, E1 totalling approximately 440,000 sq. ft. for £61 million
at an initial yield of around 8%. Jones Lang LaSalle acted for GPE and Chapman
Petrie for the joint venture. A seventh property, Associates House in Reading
(22,450 sq. ft.) was sold to Clerical and Medical Assurance for £5.16 million
at an initial yield of around 73/4%. Mason Phillips acted for Great Portland
Estates and Lambert Smith Hampton for the purchaser.
Commenting, Peter Shaw, Managing Director, said:
'The disposal of these non-core assets, comprising of almost entirely regional
offices, continues our strategy of focusing on investment and development in
London and in South East Offices. Indeed we have recently obtained planning
consent for a 19,000 sq.ft development of offices at 22/25 Northumberland
Avenue, WC2 where active steps are being taken to obtain vacant possession
with a view to commencing development before the end of the year.'
Enquiries:
Great Portland Estates PLC
020 7580 3040
Peter Shaw
Managing Director
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.